Literature DB >> 16901420

Study of the relationship between tuberous sclerosis complex and autistic disorder.

Virginia Wong1.   

Abstract

There has been increasing awareness that there are behavioral phenotypes in tuberous sclerosis complex with neuropsychiatric symptom complex such as autistic disorder and attention-deficit hyperactivity disorder (ADHD). However, the neurobiologic basis of autistic disorder in tuberous sclerosis complex is still unknown. We studied two cohorts of children followed up since 1986 until 2003, one cohort with tuberous sclerosis complex and another cohort with autistic disorder, to determine the incidence of autistic disorder in tuberous sclerosis complex and the incidence of tuberous sclerosis complex in autistic disorder respectively. We established a Tuberous Sclerosis Complex Registry in 1985 at the University of Hong Kong. In 2004, 44 index cases (the male to female ratio was 0.75:1) were registered. Three had a positive family history of tuberous sclerosis complex. Thus, the total number of tuberous sclerosis complex cases was 47. We adopted the diagnostic criteria of tuberous sclerosis complex for case ascertainment. The period prevalence rate of tuberous sclerosis complex for children and adolescents aged < 20 years is 3.5 per 10,000 (on Hong Kong island, excluding the eastern region with 125,100 aged < 20 years in 2003). Of 44 cases with tuberous sclerosis complex, 7 had autistic disorder. Thus, the incidence of autistic disorder in tuberous sclerosis complex is 16%. During the 17-year period (1986-2003), we collected a database of 753 children (668 boys and 84 girls; male to female ratio 8:1) with autistic disorder and pervasive developmental disorders. For all children with autistic disorder or pervasive developmental disorders, we routinely examined for any features of tuberous sclerosis complex by looking for neurocutaneous markers such as depigmented spots, which appear in 50% of children with tuberous sclerosis complex by the age of 2 years. For those with infantile spasm or epilepsy, the clinical features of tuberous sclerosis complex were monitored regularly during follow-up. Of these, seven had tuberous sclerosis complex. Thus, the incidence of tuberous sclerosis complex in autistic disorder is 0.9%. All of these children are mentally retarded, with moderate to severe grades in an intellectual assessment conducted by a clinical psychologist. Future studies should be directed toward looking at the various behavioral phenotypes in tuberous sclerosis complex and defining these with standardized criteria to look for any real association with the underlying genetic mutation of TSC1 or TSC2 gene or even the site of tubers in the brain.

Entities:  

Mesh:

Year:  2006        PMID: 16901420     DOI: 10.2310/7010.2006.00046

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

1.  Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.

Authors:  Jurriaan M Peters; Mustafa Sahin; Vanessa K Vogel-Farley; Shafali S Jeste; Charles A Nelson; Matthew C Gregas; Sanjay P Prabhu; Benoit Scherrer; Simon K Warfield
Journal:  Acad Radiol       Date:  2012-01       Impact factor: 3.173

Review 2.  The power and promise of identifying autism early: insights from the search for clinical and biological markers.

Authors:  Karen Pierce; Stephen J Glatt; Gregory S Liptak; Laura Lee McIntyre
Journal:  Ann Clin Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.567

3.  Longitudinal changes in diffusion properties in white matter pathways of children with tuberous sclerosis complex.

Authors:  Fiona M Baumer; Jae W Song; Paul D Mitchell; Rudolph Pienaar; Mustafa Sahin; P Ellen Grant; Emi Takahashi
Journal:  Pediatr Neurol       Date:  2015-02-16       Impact factor: 3.372

4.  Diffusion features of white matter in tuberous sclerosis with tractography.

Authors:  Michelle L Krishnan; Olivier Commowick; Shafali S Jeste; Neil Weisenfeld; Arne Hans; Matthew C Gregas; Mustafa Sahin; Simon K Warfield
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

5.  Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions.

Authors:  Jurriaan M Peters; Maxime Taquet; Anna K Prohl; Benoit Scherrer; Agnies M van Eeghen; Sanjay P Prabhu; Mustafa Sahin; Simon K Warfield
Journal:  Future Neurol       Date:  2013-09

6.  The Connectivity Fingerprint of the Fusiform Gyrus Captures the Risk of Developing Autism in Infants with Tuberous Sclerosis Complex.

Authors:  Benoit Scherrer; Anna K Prohl; Maxime Taquet; Kush Kapur; Jurriaan M Peters; Xavier Tomas-Fernandez; Peter E Davis; Elizabeth M Bebin; Darcy A Krueger; Hope Northrup; Joyce Y Wu; Mustafa Sahin; Simon K Warfield
Journal:  Cereb Cortex       Date:  2020-04-14       Impact factor: 5.357

7.  Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways.

Authors:  Anthony J Griswold; Deqiong Ma; Holly N Cukier; Laura D Nations; Mike A Schmidt; Ren-Hua Chung; James M Jaworski; Daria Salyakina; Ioanna Konidari; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Scott M Williams; Ramkumar Menon; Eden R Martin; Jonathan L Haines; John R Gilbert; Michael L Cuccaro; Margaret A Pericak-Vance
Journal:  Hum Mol Genet       Date:  2012-04-27       Impact factor: 6.150

8.  Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex.

Authors:  A L Numis; P Major; M A Montenegro; D A Muzykewicz; M B Pulsifer; E A Thiele
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

Review 9.  Autism spectrum disorders: from genes to neurobiology.

Authors:  A Jeremy Willsey; Matthew W State
Journal:  Curr Opin Neurobiol       Date:  2014-11-28       Impact factor: 6.627

10.  The Phenotypic Spectrum of Tuberous Sclerosis Complex: A Canadian Cohort.

Authors:  Daad Alsowat; Robyn Whitney; Stacy Hewson; Puneet Jain; Valerie Chan; Nadia Kabir; Kimberly Amburgey; Damien Noone; Mathieu Lemaire; Blathnaid McCoy; Maria Zak
Journal:  Child Neurol Open       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.